Viewing data from:

ERIBULIN MESYLATE

ANDA

ERIBULIN MESYLATE | A217473 | DR REDDYS LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: HALAVEN(TE code: AP)

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
EISAI R&D MANAGEMENT CO., LTD. et al v. DR. REDDYS LABORATORIES, INC. et al 2:2022cv05950 2 patentsANDA 217473eribulin mesylate	D.N.J.	2022-10-07	Terminated 2023-11-07	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain13 active DMFs

13 active API suppliers hold Drug Master Files for this ingredient.

EUROFINS CDMO ALPHORA INCERIBULIN MESYLATE

DMF 334252019

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDERIBULIN MESYLATE

DMF 351182020

FORMOSA LABORATORIES INCERIBULIN MESYLATE

DMF 353582020

WISDOM PHARMACEUTICAL CO LTDERIBULIN MESYLATE

DMF 355232021

DR REDDYS LABORATORIES LTDERIBULIN MESYLATE

DMF 364332021

EMCURE PHARMACEUTICALS LTDERIBULIN MESYLATE

DMF 365662021

NATCO PHARMA LTDERIBULIN MESYLATE

DMF 366052022

ZHEJIANG RAYBOW PHARMACEUTICAL CO LTDERIBULIN MESYLATE

DMF 373882022

CHONGQING SINTAHO PHARMACEUTICAL CO LTDERIBULIN MESYLATE

DMF 375592023

XILING LAB CO LTDERIBULIN MESYLATE

DMF 376292022

LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTDERIBULIN MESYLATE, NON-STERILE, BULK DRUG SUBSTANCE

DMF 377402023

FINETECH PHARMACEUTICAL LTDERIBULIN MESYLATE DRUG SUBSTANCE

DMF 377692024

ZENJI PHARMACEUTICALS (SUZHOU) LTDERIBULIN MESYLATE

DMF 386982023

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1MG/2ML (0.5MG/ML)

0 patents0 exclusivities▴

SOLUTION;INTRAVENOUS | Approved: Jul 3, 2025

No patent or exclusivity listings for this strength.